Cancer Death Rates Vary Across Congressional Districts
Cancer death rates in the US have declined in recent years, but the declines vary by congressional district, a study suggests.
Diagnosis & Disease Information
Adding Cixutumumab to Paclitaxel Does Not Improve Outcomes in Esophageal/GEJ Cancer
In metastatic esophageal/gastroesophageal junction cancer, the addition of cixutumumab to paclitaxel does not improve outcomes vs paclitaxel alone.
HIPEC With Mitomycin C Improves Locoregional Control in Colon Cancer
Adding HIPEC and mitomycin C to surgical resection improves locoregional control in patients with locally advanced colon cancer, a study suggests.
Muscle Strength, Sarcopenia Indicators of Nutritional Risk With Gastrointestinal Tumors
Researchers identify factors of increased nutritional risk in older adults with gastrointestinal tumors.
Prediagnostic Weight Loss Underestimates Risk for Colorectal Cancer
Association for high BMI and colorectal cancer risk most pronounced using BMI at least eight years before diagnosis.
Food Deserts, Swamps Linked to Increased Risk of Death From Obesity-Related Cancers
US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.
Sex Hormones Linked to Risk of Gastrointestinal Cancers
Higher levels of certain sex hormones are associated with an increased risk of some gastrointestinal cancers, a meta-analysis suggests.
New Scale Quantifies Workload, Increases Productivity of Oncology Nurse Navigators
Study results show a new productivity scale measures the workloads of oncology nurse navigators and assists in increasing their productivity.
ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.
Adding Bevacizumab to Trifluridine-Tipiracil Improves PFS, OS in Metastatic CRC
Adding bevacizumab to treatment with trifluridine-tipiracil improves outcomes in patients with refractory, metastatic colorectal cancer, a phase 3 study suggests.
- Loading...
Loading...
Next post in Colorectal Cancer
Loading... 
Loading...